{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T07:52:39Z","timestamp":1697010759837},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,3,15]]},"DOI":"10.2146\/ajhp140025","type":"journal-article","created":{"date-parts":[[2015,3,4]],"date-time":"2015-03-04T00:36:32Z","timestamp":1425429392000},"page":"449-452","source":"Crossref","is-referenced-by-count":5,"title":["Probable boceprevir-induced hyponatremia in a patient with chronic hepatitis C"],"prefix":"10.1093","volume":"72","author":[{"given":"Kristen T.","family":"Hedrick","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, HealthSpan, Brooklyn Heights, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannon M.","family":"Just","sequence":"additional","affiliation":[{"name":"Medication Management Clinic, Department of Clinical Pharmacy, HealthSpan, Parma, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel R.","family":"Kahn","sequence":"additional","affiliation":[{"name":"Department of Nephrology, HealthSpan Physicians, Cleveland Heights, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t2019041008215319600_b1-0720449","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/PHAR.1046","article-title":"Boceprevir: a novel NS3\/4 protease inhibitor for the treatment of hepatitis C","volume":"32","author":"Klibanov","year":"2012","journal-title":"Pharmacotherapy"},{"key":"key\n\t\t\t\t2019041008215319600_b2-0720449","article-title":"Boceprevir [monograph]","volume-title":"Lexicomp Online [online database]"},{"key":"key\n\t\t\t\t2019041008215319600_b3-0720449","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t2019041008215319600_b4-0720449","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ijmedinf.2007.08.010","article-title":"A quantitative approach of using genetic algorithm in designing a probability scoring system of an adverse drug reaction assessment system","volume":"77","author":"Koh","year":"2008","journal-title":"Int J Med Inform"},{"key":"key\n\t\t\t\t2019041008215319600_b5-0720449","first-page":"745","article-title":"Disorders of sodium and water homeostasis","volume-title":"Pharmacotherapy: a pathophysiologic approach","author":"Matzke","year":"2011","edition":"8th"},{"key":"key\n\t\t\t\t2019041008215319600_b6-0720449","first-page":"772","article-title":"Urinalysis and urine electrolytes","volume-title":"Principles and practice of hospital medicine","author":"Schaffer","year":"2012"},{"key":"key\n\t\t\t\t2019041008215319600_b7-0720449","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1053\/j.ajkd.2008.03.004","article-title":"A review of drug-induced hyponatremia","volume":"52","author":"Liamis","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t2019041008215319600_b8-0720449","unstructured":"Food and Drug Administration. Victrelis (boceprevir) medical review. www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2011\/202258Orig1s000MedR.pdf (accessed 2013 Jun 12)."},{"key":"key\n\t\t\t\t2019041008215319600_b9-0720449","first-page":"70","article-title":"Association of prenatal and postnatal exposure to lopinavirritonavir and adrenal dysfunction among uninfected infants of HIV-infected mothers","volume":"306","author":"Warszawksi","year":"2011","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041008215319600_b10-0720449","first-page":"21","article-title":"Interferon-alpha is a predisposing risk factor for carbamazepine-induced hyponatremia: a case of syndrome of inappropriate antidiuresis caused by interferon-alpha therapy","volume":"1","author":"Tanaka","year":"2008","journal-title":"Int J Gen Med"},{"key":"key\n\t\t\t\t2019041008215319600_b11-0720449","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/02841860802047403","article-title":"Severe hyponatremia caused by hyperglycaemia due to interferon alpha therapy in advanced renal cell carcinoma","volume":"48","author":"Soetekouw","year":"2009","journal-title":"Acta Oncol"},{"key":"key\n\t\t\t\t2019041008215319600_b12-0720449","doi-asserted-by":"crossref","first-page":"939","DOI":"10.2169\/internalmedicine.47.0990","article-title":"Conversion from latent to symptomatic Sheehan\u2019s syndrome by pegylated interferon therapy for chronic hepatitis C","volume":"47","author":"Kanda","year":"2008","journal-title":"Intern Med"},{"key":"key\n\t\t\t\t2019041008215319600_b13-0720449","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/ajh.2830490123","article-title":"Severe hyponatremia due to syndrome of inappropriate secretion of antidiuretic hormone in a patient receiving interferon-alpha for chronic myeloid leukemia","volume":"49","author":"Lei","year":"1995","journal-title":"Am J Hematol"},{"key":"key\n\t\t\t\t2019041008215319600_b14-0720449","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10637-007-9091-2","article-title":"A phase II trial of doxorubicin and interferon alpha 2b in advanced, non-medullary thyroid cancer","volume":"26","author":"Argiris","year":"2008","journal-title":"Invest New Drugs"},{"key":"key\n\t\t\t\t2019041008215319600_b15-0720449","first-page":"511","article-title":"A case of Addison\u2019s disease which became worse during interferon therapy: insulin secretion under hypoosmolarity","volume":"70","author":"Oshimoto","year":"1994","journal-title":"Nihon Naibunpi Gakkae Zasshi"},{"key":"key\n\t\t\t\t2019041008215319600_b16-0720449","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1749-6632.1998.tb09621.x","article-title":"Glucocorticoid resistance and the immune function in the immunodeficiency syndrome","volume":"840","author":"Norbiato","year":"1998","journal-title":"Ann N Y Acad Sci"},{"issue":"suppl 1","key":"key\n\t\t\t\t2019041008215319600_b17-0720449","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/S0306-4530(97)00011-5","article-title":"Glucocorticoids and the immune system in AIDS","volume":"22","author":"Norbiato","year":"1997","journal-title":"Psychoneuroendocrinology"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/72\/6\/449\/28319197\/ajhp0449.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T16:24:06Z","timestamp":1566404646000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/72\/6\/449\/5111487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,15]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,3,15]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp140025","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,3,15]]},"published":{"date-parts":[[2015,3,15]]}}}